Metraipolis › archive › dc_535986fcd8da
The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trial — Europe PMC PMID:42108271
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42108271
- DOI
- 10.1038/s41591-[numero omesso]-4
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T13:13:24.023Z
- SHA-256 of the archived text
61c8b6ad0d79954d0adfd7e2f646a89b78b87df0661bb9ced7074716c580c985- Stable URL of this page
https://metraipolis.com/documento/dc_535986fcd8da
How to cite
The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trial — Europe PMC PMID:42108271 — Europe PMC (en), https://europepmc.org/article/MED/42108271 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_535986fcd8da (Metraipolis archive dc_535986fcd8da, sha256 61c8b6ad0d79954d0adfd7e2f646a89b78b87df0661bb9ced7074716c580c985)
BibTeX
@misc{dc535986fcd8da,
title = {The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trial — Europe PMC PMID:42108271},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42108271},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_535986fcd8da; sha256 61c8b6ad0d79954d0adfd7e2f646a89b78b87df0661bb9ced7074716c580c985},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42108271. Agents can read the archived copy with the MCP tool read_document.